BACKGROUND: Sin Nombre virus (SNV) establishes a persistent infection in the deer mouse, Peromyscus maniculatus. A strong antibody response occurs in response to SNV infection, but the role of the innate immune response is unclear. To address this issue, we have initiated an effort to identify and characterize deer mouse cytokine and chemokine genes. Such cytokines and chemokines are involved in various aspects of immunity, including the transition from innate to adaptive responses, type I and type II responses, recruitment of leukocytes to sites of infection, and production of mature cells from bone marrow progenitors. RESULTS: We established a colony of SNV antibody-negative deer mice and cloned 11 cytokine and chemokine partial cDNA sequences using directed PCR. Most of the deer mouse sequences were highly conserved with orthologous sequences from other rodent species and functional domains were identified in each putative polypeptide. CONCLUSIONS: The availability of these sequences will allow the examination of the role of these cytokines in deer mouse responses to infection with Sin Nombre virus.
BACKGROUND:Sin Nombre virus (SNV) establishes a persistent infection in the deer mouse, Peromyscus maniculatus. A strong antibody response occurs in response to SNV infection, but the role of the innate immune response is unclear. To address this issue, we have initiated an effort to identify and characterize deer mouse cytokine and chemokine genes. Such cytokines and chemokines are involved in various aspects of immunity, including the transition from innate to adaptive responses, type I and type II responses, recruitment of leukocytes to sites of infection, and production of mature cells from bone marrow progenitors. RESULTS: We established a colony of SNV antibody-negative deer mice and cloned 11 cytokine and chemokine partial cDNA sequences using directed PCR. Most of the deer mouse sequences were highly conserved with orthologous sequences from other rodent species and functional domains were identified in each putative polypeptide. CONCLUSIONS: The availability of these sequences will allow the examination of the role of these cytokines in deer mouse responses to infection with Sin Nombre virus.
Deer mice (Peromyscus maniculatus) are the principal natural host of Sin Nombre virus (SNV), the etiologic agent of most hantavirus pulmonary syndrome (HPS) cases in humans in North America [1-3]. Deer mice are found throughout most of North America, except for the eastern seaboard and southeast United States [4].SNV predominantly infects capillary endothelial cells without discernible pathology [5]. A prominent feature of HPS is capillary leakage and subsequent hypotension that causes death by cardiac failure. In addition to resident alveolar macrophages, lymphocytes infiltrate the lungs of patients and contribute to the pathology by secreting proinflammatory cytokines, including interferon-γ (IFNγ), interleukin-2 (IL-2), tumor necrosis factor (TNF), and lymphotoxin (LT) [6]. These characteristics suggest HPS may be a cytokine-mediated immunopathology.As is usual with most long-term reservoir hosts, deer mice exhibit little pathology during acute infection with SNV [7]. The virus infects capillary endothelial cells of deer mouse lungs, but lymphocyte infiltration or inflammation are not observed. After acute infection, the virus establishes persistence in many tissues [8] and most, if not all, deer mice remain infected for the remainders of their lives.The role of the immune response in infected deer mice is unclear because few reagents of defined specificity have been developed to characterize their immune function. A strong IgG antibody response occurs [7,9], suggesting that B cells and helper T cells participate in containment of the virus, but the role of cytokines has not been characterized. As part of our continuing efforts to develop the deer mouse as a model for SNV research [10,11]; (Green et al., in press; Richens et al., submitted), we established a colony of deer mice captured in a region where SNV is prevalent [12,13]. Splenocytes obtained from deer mice from this colony were used to clone several cytokine and chemokine cDNA sequences. These sequences represent several components of the immune response, including the transition from innate to adaptive responses (IL-12a, IL-21, IL-23a), type I (IL-2) and type II responses (IL-6, IL-13), a colony stimulating factor (GM-CSF), and chemokines (CCL2, CCL3, CCL4, CXCL2). The availability of such sequences will permit experimental examination of the roles of these cytokines in deer mice infected with SNV.
Results
Establishment of a deer mouse colony
We identified a location that contained SNV-infected deer mice and trapped 10 deer mice. Nine (4 males and 5 females) had no IgG antibody to SNV at capture, as well as after 36 days of quarantine [14], and were used to establish the colony. Breeders were kept on a 16:8 light:dark cycle and were provided food and water ad libitum. The colony has been reproductively vigorous and has produced nearly 300 offspring in 3 years.
Interleukins
The fragment encoding deer mouseIL-2 was 456 nucleotides (nt) in length and represents all but the final three amino acids (Figure 1) based upon the known sequence of house mouseIL-2. House mouseIL-2 exhibits an unusual N-terminal structure that is not present in IL-2 of the other species. Discounting this region, deer mouseIL-2 shares 76% identity and 82% similarity to house mouseIL-2. As with the other species, deer mouseIL-2 possesses a 20 residue signal sequence. All three cysteines are conserved in IL-2 orthologs and C72 and C120 of the deer mouse polypeptide are predicted to form an intrachain disulfide bond [15]. The threonine at position 3 of the mature polypeptide is conserved and serves as a potential glycosylation site [16]. The predicted α-helices (A-F) are present, although helix F is incomplete [15].
Figure 1
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-2. The house mouse, rat and human sequences were truncated to align with the cloned deer mouse fragment. The sequence accession numbers are listed in Table 3 and were aligned using the clustalw multiple alignment algorithm in MacVector DNA analysis software. Identical amino acids are boxed with dark background, similar amino acids are boxed with light background, and nonidentities have white background. The deer mouse polypeptide represents all but the final 3 amino acids. An unusual feature of house mouse IL-2 is the presence of a serine- and glutamine-rich region near the N-terminus. A conserved threonine (+) that is a potential glycosylation site is located at position 3. All three cysteine residues are conserved in deer mouse IL-2 and it is predicted that a disulfide bond is formed between C72 and C120 (*). Conserved residues involved in receptor binding are located at positions 20 and 42 (^). The predicted alpha helices are denoted by lettered (A-F) underlines.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-2. The house mouse, rat and human sequences were truncated to align with the cloned deer mouse fragment. The sequence accession numbers are listed in Table 3 and were aligned using the clustalw multiple alignment algorithm in MacVector DNA analysis software. Identical amino acids are boxed with dark background, similar amino acids are boxed with light background, and nonidentities have white background. The deer mouse polypeptide represents all but the final 3 amino acids. An unusual feature of house mouseIL-2 is the presence of a serine- and glutamine-rich region near the N-terminus. A conserved threonine (+) that is a potential glycosylation site is located at position 3. All three cysteine residues are conserved in deer mouseIL-2 and it is predicted that a disulfide bond is formed between C72 and C120 (*). Conserved residues involved in receptor binding are located at positions 20 and 42 (^). The predicted alpha helices are denoted by lettered (A-F) underlines.
Table 3
Accession numbers of polypeptide sequences used for alignments in this work.
Gene
Homo sapiens
Rattus rattus
Mus musculus
Peromyscus maniculatus
IL-2
1009281A
NP_446288
X01772
AY247760
IL-6
P05231
NP_036721
NM_031168
AY256518
IL-12a
NP_000873
NP_445842
NM_008351
AY247763
IL-13
P35225
NP_446280
NM_008355
AY311480
IL-21
NP_068575
XP_227047
NM_021782
AY247761
IL-23a
NP_057668
NP_569094
NM_031252
AY259629
GM-CSF
NP_000749
P48750
X02333
AY247762
CCL2
NP_002973
NP_113718
NM_011333
AY271904
CCL3
P10147
AAA80608
NM_011337
AY247759
CCL4
P13236
P50230
NM_013652
AY247758
CXCL2
NP_002080
NP_446099
NM_009140
AY271905
We cloned a 225 nt fragment of deer mouseIL-6 that encodes the 53 C-terminal residues, which represents 25% of the coding region (Figure 2). The polypeptide shares 66% identity and 70% similarity with house mouseIL-6. The polypeptide possesses the predicted D (E25-R51) and E (P10-E21) helices [17]. The tryptophan at 157 that is involved in receptor interaction [18] is conserved in deer mouseIL-6, as is the arginine at position 48. Mutations in this residue have been shown to reduce IL-6 activity by 100-fold [19].
Figure 2
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-6. Sequences were aligned as described in Figure 1. The fragment represents approximately 25% of the polypeptide. The E and D helices (underlined) and residues implicated in receptor binding are denoted (*).
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-6. Sequences were aligned as described in Figure 1. The fragment represents approximately 25% of the polypeptide. The E and D helices (underlined) and residues implicated in receptor binding are denoted (*).The cloned IL-12a fragment is 185 nt and represents 28% of the polypeptide (IL-12 p35, Figure 3). It shares 62% identity and 74% similarity with house mousep35 and includes the first 60 residues of the mature polypeptide. The humanp35 polypeptide has four consecutive residues not found in the rodent p35 polypeptides (D9-M12). Conserved cysteines are found at positions 15 and 42, the latter of which is involved in intrachain disulfide bond formation [20]. The conserved arginine at position 34 plays a role in the interchain interface with the IL-12 p40 subunit. Helix A, which provides a large interlocking topology for the p40 subunit, is present in the deer mouse polypeptide.
Figure 3
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-12a. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 28% of the polypeptide. The polypeptide includes helix A (underlined) and conserved cysteines noted with an asterisk (*). The conserved arginine (+) is involved with dimerization to the p40 subunit.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-12a. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 28% of the polypeptide. The polypeptide includes helix A (underlined) and conserved cysteines noted with an asterisk (*). The conserved arginine (+) is involved with dimerization to the p40 subunit.The cloned deer mouseIL-13 fragment is 184 nt in length and represents 47% of the coding region (Figure 4). It possesses 76% identity and 84% similarity to house mouseIL-13. The deer mouse polypeptide includes helices B (G14-T23) and C (Y32-G40), and the first three residues of helix D (V63-H65) [21]. It also includes both the β1 (M4-S6) and β2 (D58-I61) strands and the amino acids are completely conserved between the rodent and human sequences. A hydrogen bond between V5 and I61 of these interloop strands is predicted to structurally stabilize IL-13. Three of the four expected cysteines that form intrachain disulfide bonds are present. The deer mouseIL-13 fragment is four amino acids shorter than the human fragment, while the house mouse and rat fragments are three residues shorter than the human fragment. These differences are between helix C and the β2 strand.
Figure 4
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-13. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 47% of the polypeptide. The fragment includes helices B and C and part of helix D, and both β-strands (underlined). Three of the four expected cysteines (*) involved in intrachain disulfide bonds are also present.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-13. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 47% of the polypeptide. The fragment includes helices B and C and part of helix D, and both β-strands (underlined). Three of the four expected cysteines (*) involved in intrachain disulfide bonds are also present.The cloned IL-21 fragment is 371 nt in length and represents 84% of the coding region (Figure 5). It shares 81% identity and 86% similarity with house mouseIL-21. The polypeptide includes the first three and part of the fourth helices (A 9–24; B 36–52; C 59–73; D 102–105) typical of the four-helix-bundle family of cytokines [22]. Residue D12, believed to be involved in receptor interaction, is conserved in all four species [23].
Figure 5
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-21. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 84% of the polypeptide and includes the first three and part of the fourth helices (A-D, underlined). Conserved cysteines (*) and an aspartic acid (+) involved in receptor binding are also present in deer mouse IL-21.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-21. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 84% of the polypeptide and includes the first three and part of the fourth helices (A-D, underlined). Conserved cysteines (*) and an aspartic acid (+) involved in receptor binding are also present in deer mouseIL-21.The cloned IL-23a cDNA is 579 nt and represents 94% of the coding region, including the complete N-terminus (Figure 6). The polypeptide is 81% identical and 86% similar to house mouseIL-23a. The fragment contains all five cysteine residues and all four helices are present (A Q12-V31; B Q68-T91; C L97-Q117; D Q136-Q165) [24].
Figure 6
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-23a. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 94% of the polypeptide. All five cysteines (*) are present as well as the four α-helices (A-D, underlined).
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) IL-23a. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 94% of the polypeptide. All five cysteines (*) are present as well as the four α-helices (A-D, underlined).
GM-CSF
The granulocyte macrophage-colony stimulating factor (GM-CSF) fragment is 175 nt long and represents 39% of the coding region (Figure 7). It shares 65% identity and 73% similarity to house mouseGM-CSF. All of helix B (V40-G50) and parts of helices A (V1-D12) and C (K59-A61) are present in the fragment [25]. The first β-strand is located at positions I27-S29. The cysteine at position 39 participates in one of two intrachain disulfide bonds. The A helix is highly conserved between rodents and plays an important role in binding to the GM-CSF receptor [26].
Figure 7
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) GM-CSF. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 39% of the polypeptide. It includes partial A and C helices and the entire B helix and the β1-strand (underlined). One conserved cysteine is also present in deer mouse GM-CSF (*).
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) GM-CSF. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 39% of the polypeptide. It includes partial A and C helices and the entire B helix and the β1-strand (underlined). One conserved cysteine is also present in deer mouseGM-CSF (*).
Chemokines
The CCL2 fragment is 297 nt and encodes 60% of the polypeptide (Figure 8). It is 61% identical and 75% similar to house mouseCCL2. The rodent CCL2 polypeptides are 43 residues longer than humanCCL2. The third and fourth conserved cysteines (C6, C22) are also present in the deer mouse polypeptide. Residues 1–6 of the polypeptide form a loop that is important in forming the homodimer interface of CCL2 [27]. A β-sheet is preserved from A10-T15 as well as a β-strand from L17-R19. A helix is encoded from W29-Q39.
Figure 8
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CCL2. Sequences were aligned as described in Figure 1. The fragment represents 60% of the polypeptide. Conserved secondary structures (underlined) and cysteines are present in deer mouse CCL2. Two highly conserved regions that form the homodimer interface are also conserved in deer mouse CCL2. Rodent CCL2 polypeptides are substantially longer than human CCL2.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CCL2. Sequences were aligned as described in Figure 1. The fragment represents 60% of the polypeptide. Conserved secondary structures (underlined) and cysteines are present in deer mouseCCL2. Two highly conserved regions that form the homodimer interface are also conserved in deer mouseCCL2. Rodent CCL2 polypeptides are substantially longer than humanCCL2.The CCL3 fragment is 260 nt and encodes the last 41 residues (Figure 9). It represents 45% of the polypeptide and exhibits 83% identity and 90% similarity to house mouseCCL3. The deer mouse polypeptide possesses the β2 (G10-K16) and β3 (N18-D24) strands as well as the C-terminal α-helix (V30-L37) [28]. The third (C6) and fourth (C22) cysteines involved with intrachain disulfide bonds were also present.
Figure 9
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CCL3. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 45% of the polypeptide and includes the second and third β-strands, and the α-helix (underlined). The third and fourth conserved cysteines (*) are also present.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CCL3. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 45% of the polypeptide and includes the second and third β-strands, and the α-helix (underlined). The third and fourth conserved cysteines (*) are also present.The CCL4 fragment is 257 nt fragment and represents all but the last 7 expected amino acids (Figure 10). It shares 80% identity and 87% similarity with house mouseCCL4. The polypeptide includes all four conserved cysteines that form intrachain disulfide bonds (C11-C35, C12-C51) [28], including the adjacent cysteines that are the hallmark of CC chemokines. All three β-strands are present (β1 T26-T31; β2 A39-R45; β3 G47-D53) as is the α-helix (W58-Y62).
Figure 10
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CCL4. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 92% of the polypeptide. All four conserved cysteines (*) and all three β-strands are present, as is part of the α-helix.
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CCL4. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 92% of the polypeptide. All four conserved cysteines (*) and all three β-strands are present, as is part of the α-helix.The CXCL2 fragment is 198 nt long, encodes the last 36 amino acids, and represents about half of the mature polypeptide (Figure 11). It shares 92% identity and similarity to house mouseCXCL2. The fourth conserved cysteine involved in intrachain disulfide bond formation is residue 14 [29]. The β2 (E2-L7) and β3 (Q11-L15) strands that are involved in homodimer formation are also present, as is the C-terminal α-helix (R23-L30).
Figure 11
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CXCL2. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 49% of the polypeptide and possesses the last two β-strands, the α-helix, and the fourth conserved cysteine (*)
Amino acid alignment of deer mouse (Pema), house mouse (Mus), rat (Rattus) and human (Homo) CXCL2. Sequences were aligned as described in Figure 1. The deer mouse fragment represents 49% of the polypeptide and possesses the last two β-strands, the α-helix, and the fourth conserved cysteine (*)
Discussion
Pathogenic hantaviruses induce acute inflammatory responses in humans that contribute to HPS disease progression [5,6]. Much of the pathology occurs because of the production of several inflammatory cytokines in the lungs, including IL-2, IFNγ, tumor necrosis factor (TNF) and lymphotoxin (LT). In addition, pulmonary T cell infiltrates are observed in patients that die from HPS. It is evident that immunopathology contributes to HPS progression, given that SNV does not cause discernible direct cytopathology.We targeted several deer mouse cytokines important in different aspects of immune responses. Our approach was to identify highly conserved regions of orthologous sequences from rodents and humans and to design primers from them. In many instances no consensus was found, so degenerate primer sets were used. In our analysis we determined the approximate relative sizes of the fragments based upon the known length of M. musculus orthologs; it is likely that some deer mouse genes will be longer or shorter when full-length sequences become available.We also used cells from ostensibly SNV-susceptible deer mice. It is plausible that, in response to coadaptation with the virus, some selective pressure has occurred over time on deer mouse cytokine genes.IL-2 is the principal T cell growth factor and is secreted by T helper 1 (Th1) cells during immune responses [30,31]. It is also produced by pulmonary infiltrates in HPSpatients [6] and probably plays an indirect role in inflammation by augmenting TNF expression [32]. IL-21 is an IL-2 family member that is also secreted by Th1 cells. It was initially described as an activator of NK cells and an augmenter of B cell and T cell proliferation [22]. More recently, it has been shown to play a role in the transition from innate to adaptive responses by limiting NK cell responses and activating cytotoxic T lymphocyte responses [33]. It also skews the immune response towards a type I response by augmenting expression of the T-bet transcription factor, IFNγ and receptors for IL-2, IL-12 and IL-18 [34].Although GM-CSF is secreted by Th1 cells [31], it is commonly used to generate bone marrow-derived dendritic cells (DC). The receptor-binding region of deer mouseGM-CSF is highly conserved with respect to house mouse and ratGM-CSF. This suggested to us that recombinant house mouseGM-CSF (rGM-CSF), which is commercially available, might bind to the deer mouseGM-CSF receptor, and we have obtained preliminary evidence suggesting that it does (data not shown). Human DC have recently been shown to support the replication of Hantaan virus [35], which is related to SNV. It should be possible to generate deer mouse DC with rGM-CSF to determine whether they can be infected by SNV and to determine whether there is a functional consequence of infection.Both IL-12a and IL-23a polypeptides form heterodimers with the IL-12b (p40) subunit to form IL-12 and IL-23, respectively [24,36]. IL-12 facilitates the transition from the innate response to a type I adaptive immune response, while IL-23 appears to sustain proliferation of Th1 cells during the course of an immune response [24,37]. Both are produced by macrophages and dendritic cells and influence T cell maturation towards a Th1 phenotype.In addition to Th2 cells, IL-6 is expressed by many other cell types and has broad biological activity, including a major role in augmenting antibody production in activated B cells [38]. IL-13 is closely linked to the IL-4 gene cluster in humans and house mice and has a role in class switching and controlling inflammatory responses [39,40].Chemokine production in humans infected with SNV has not been examined in detail. TNF is produced in the lungs of patients that die from HPS [6] and mononuclear infiltrates are present in pulmonary tissues [5]. Since chemokines are potent recruiters of blood leukocytes into infected tissues, there must be a prominent role for these proteins in HPS. Deer mice exhibit no conspicuous recruitment of leukocytes into the lungs [7], thus comparison of chemokine responses in humans and deer mice infected with SNV may provide clues as to how their respective immune systems respond to the virus and how the virus evades the immune response in deer mice to establish persistence.We did not find any conspicuous differences in the amino acid sequences of deer mouse cytokines or chemokines compared to rat or house mouse orthologs that would suggest a functional difference in the mechanism by which these molecules exert their effects in vivo. More likely, immunological decisions are made during acute infection in deer mice that lead to a qualitative difference in cytokine profiles. These sequences and others that we previously reported [11] will be useful in characterizing cytokine and chemokine responses in deer mice. By comparing the profiles of these responses in deer mice and humans, it is possible that therapeutic targets can be identified in humans infected with hantaviruses. For HPS, treatment strategies must function quickly because of the rapidity of patient decline; death can occur within hours after medical treatment is sought [5,41]. Although antiviral drugs may be developed against the virus, it is likely that an immunomodulatory approach that prevents or reverses pulmonary inflammation would be useful in treating patients.We believe that the primer sets developed in this work can be used to amplify orthologous sequences from a variety of rodent species. Deer mice are New World rodents, while house mice and rats (Rattus sp.) are Old World rodents. Deer mice are about 50 million years divergent (myd) from house mice, while house mice and the laboratory rat (R. rattus) are only 15–25 myd [42]. We attempted to perform phylogenetic analyses; however, the short fragments representing most of the genes possessed insufficient data for meaningful interpretation. We are currently pursuing additional sequence data to address this deficiency (Palmer et al., manuscript in preparation).
Conclusions
We have cloned a number of deer mouse cytokine and chemokine cDNA sequences. These represent several components of immune responses, including transition from innate to adaptive immunity, type I and type II responses, chemotaxis, and a cytokine useful for producing mature monocytic cells from bone marrow. The availability of these sequences will allow the characterization of a portion of the cytokine and chemokine responses in deer mice acutely or persistently infected with SNV.
Methods
Establishment of deer mouse colony
Deer mice were trapped under license from the Colorado Division of Wildlife. Sherman live traps were set at a site where deer mice are known to occur (N 38° 59' 18.9", W 108° 17' 13.3") [12] and baited as described elsewhere [13]. Ten captured deer mice (P. maniculatus nebrascensis) were trapped and bled from the retro-orbital capillary beds and tested for IgG antibody by a standard enzyme-linked immunosorbent assay (ELISA) [43]. Each deer mouse was quarantined outdoors in the shade in buried (10 cm) 20 L plastic buckets with ventilated sealed lids, bedding, lab mouse chow, and apple slices for water and inspected daily. None of the animals died during the quarantine period. One deer mouse was seropositive at capture and was discarded. At day 30 of quarantine, the deer mice were again bled and tested for IgG antibody to SNV by ELISA and still were seronegative. On day 36 of the quarantine, the 9 uninfected deer mice were transported to Mesa State College where they were used to establish a colony with approval of the Institutional Animal Care and Use Committee.
Cloning and sequencing of deer mouse cytokines and chemokines by directed RT-PCR
The procedure for cloning deer mouse genes has been described elsewhere [11]. Briefly, total RNA was extracted from splenocyte cultures stimulated with concanavalin A or lipopolysaccharide and reverse transcribed with oligo-dT primers (Superscript II, Invitrogen, Carlsbad, CA). Degenerate primer sets were designed from highly conserved orthologous sequences from other rodent species and humans (Table 2). First attempts for PCR amplification (PCR Core Kit, Qiagen, Valencia, CA) were done with 58°C annealing temperature. If products were not amplified, PCR was repeated with 5 cycles of 58°C annealing, 5 cycles of 54°C annealing, then 27 cycles with 58°C annealing. Amplicons were cloned into pGEM-T Easy (Promega, Madison, WI) and transformed into NovaBlue competent cells (Novagen, Madison, WI). In some instances it was necessary to gel-purify PCR products (NucleoTrap, CLONTech, Palo Alto, CA). Colonies were screened by PCR and those with inserts were grown in LB/amp broth and the plasmids sequenced (Big Dye Terminator, Applied Biosystems Inc., Foster City, CA) using an ABI 310 DNA Analyzer. Sequences from three independent clones for each gene were assembled using Sequencher 4 software and identified by BLAST against house mouse entries in Genbank. House mouse, rat and human sequences (Table 3) were downloaded from the NCBI and used for comparative analysis with deer mouse sequences using the clustal algorithm [44] in MacVector software (Accelerys, San Diego, CA) and its default translation table. Amino acid gaps were considered nonidentities.
Table 2
Primer sets used to clone deer mouse cDNA sequences.
Gene
Forward Primer1
Reverse Primer
IL-2
ATG TAC AGC AKG CAG CTC GC
TGT TGA GAT GRY RCT TTG AC
IL-6
GAG RGR AGA CTT CAC AGA GG
CAG GAT ATR TTT TCT GAC CAC AG
IL-12a
RAC CAC CTC AST TYG GCC AG
TGG TAC ATC TTC AAG TCY TC
IL-13
CAA YRG CAG CAT GGT ATG GAG
STG GGC YAC YTC GAT TTT GG
IL-21
GTA GTC ATC TTC TTG GGG AC
CTT TCT AGG AAT TCT TTG GG
IL-23a
AGC CAG ATC TGA GAA GCA GG
CTG CTC CRT GGG CAA AGA CC
GM-CSF
GTA GAK GCC ATC AAA GAA GC
AGG CRC CMT TGA GTT TGG TG
CCL2
ATC ACC AGC AGC ARG TGT CC
RRT CAC ACT AGT TCW CTG TC
CCL3
SAG ACC AGC AGC CTT TGC TC
RRT GTG GCT ACT TGG CAG C
CCL4
ACC ATG AAG CTC TGC CTG TC
RTA CTC ATT GAC CCA GGG C
CXCL2
GAC RGA AGT CAT AGC CAC TC
TCA GGW ACG ATC CAG GCT TC
1Sequences are listed 5' to 3'. IUPAC nomenclature: K = G or T; R = A or G; Y = C or T; S = C or G; M = A or C; W = A or T.
Deer mouse cytokine and chemokine cDNA sequences compared to house mouse, rat, and human orthologs.1Estimated coding region is based upon length of house mouse polypeptide. 2Similarity is based upon amino acid comparisons, where gaps are treated as nonidentities, except as noted in the text for IL-2 (house mouse) and CCL2 (human).Primer sets used to clone deer mouse cDNA sequences.1Sequences are listed 5' to 3'. IUPAC nomenclature: K = G or T; R = A or G; Y = C or T; S = C or G; M = A or C; W = A or T.
List of Abbreviations
IL, interleukin; CC, CC chemokine; CXC, CXC chemokine; GM-CSF, granulocyte macrophage-colony stimulating factor; SNV, Sin Nombre virus; TNF, tumor necrosis factor; IFNγ, interferon-γ ; LT, lymphotoxin
Authors' Contributions
TS provided conceptual efforts on establishment of the colony and the overall cloning strategy and cloned the IL-13, IL-23a, CCL2 and CXCL2 genes. RG cloned and sequenced the IL-6 gene. BD cloned and sequenced the GM-CSF gene. AB cloned the IL-2 and IL-21 genes. TH cloned and sequenced the IL-12a, CCL3 and CCL4 genes. JJR supervised the trapping and bled the deer mice. FD cared for the deer mice during the quarantine period. CHC and BJB performed diagnostic testing of the deer mouse serum samples for SNV infection.Accession numbers of polypeptide sequences used for alignments in this work.
Table 1
Deer mouse cytokine and chemokine cDNA sequences compared to house mouse, rat, and human orthologs.
Similarity (%) to:2
Gene
Size (bp)
Est. coding region (%)1
House mouse
Rat
Human
IL-2
456
98
82
89
80
IL-6
225
25
70
83
40
IL-12a
185
28
74
75
69
IL-13
184
47
84
80
71
IL-21
371
84
86
84
70
IL-23a
579
94
86
91
83
GM-CSF
175
39
73
69
62
CCL2
297
60
75
82
70
CCL3
260
45
90
88
81
CCL4
257
92
87
88
86
CXCL2
198
49
92
92
69
1Estimated coding region is based upon length of house mouse polypeptide. 2Similarity is based upon amino acid comparisons, where gaps are treated as nonidentities, except as noted in the text for IL-2 (house mouse) and CCL2 (human).
Authors: H Feldmann; A Sanchez; S Morzunov; C F Spiropoulou; P E Rollin; T G Ksiazek; C J Peters; S T Nichol Journal: Virus Res Date: 1993-12 Impact factor: 3.303
Authors: S T Nichol; C F Spiropoulou; S Morzunov; P E Rollin; T G Ksiazek; H Feldmann; A Sanchez; J Childs; S Zaki; C J Peters Journal: Science Date: 1993-11-05 Impact factor: 47.728
Authors: J Punnonen; G Aversa; B G Cocks; A N McKenzie; S Menon; G Zurawski; R de Waal Malefyt; J E de Vries Journal: Proc Natl Acad Sci U S A Date: 1993-04-15 Impact factor: 11.205
Authors: A N McKenzie; J A Culpepper; R de Waal Malefyt; F Brière; J Punnonen; G Aversa; A Sato; W Dang; B G Cocks; S Menon Journal: Proc Natl Acad Sci U S A Date: 1993-04-15 Impact factor: 11.205
Authors: L H Elliott; T G Ksiazek; P E Rollin; C F Spiropoulou; S Morzunov; M Monroe; C S Goldsmith; C D Humphrey; S R Zaki; J W Krebs Journal: Am J Trop Med Hyg Date: 1994-07 Impact factor: 2.345
Authors: S R Zaki; P W Greer; L M Coffield; C S Goldsmith; K B Nolte; K Foucar; R M Feddersen; R E Zumwalt; G L Miller; A S Khan Journal: Am J Pathol Date: 1995-03 Impact factor: 4.307
Authors: G Paonessa; R Graziani; A De Serio; R Savino; L Ciapponi; A Lahm; A L Salvati; C Toniatti; G Ciliberto Journal: EMBO J Date: 1995-05-01 Impact factor: 11.598
Authors: Charles H Calisher; James E Childs; Hume E Field; Kathryn V Holmes; Tony Schountz Journal: Clin Microbiol Rev Date: 2006-07 Impact factor: 26.132
Authors: Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle Journal: Proc Natl Acad Sci U S A Date: 2007-09-17 Impact factor: 11.205
Authors: Malin Stoltz; Karin B Sundström; Åsa Hidmark; Conny Tolf; Sirkka Vene; Clas Ahlm; A Michael Lindberg; Åke Lundkvist; Jonas Klingström Journal: PLoS One Date: 2011-12-16 Impact factor: 3.240
Authors: Clifton M Ramsdell; Adrienne A Lewandowski; Julie L Weston Glenn; Paul B Vrana; Rachel J O'Neill; Michael J Dewey Journal: BMC Evol Biol Date: 2008-02-26 Impact factor: 3.260
Authors: Bennett J Davenport; Derall G Willis; Joseph Prescott; Regina M Farrell; Teresa A Coons; Tony Schountz Journal: BMC Immunol Date: 2004-09-30 Impact factor: 3.615